Специфическое лечение ЖЛ отсутствует. Применяется симптоматическое лечение: введение жидкостей, анальгетиков, противовоспалительных препаратов. Изоляция больных в помещениях без доступа комаров.
Литература
Лекции по тропической медицине: в 10 ч. Часть 1. Геморрагические лихорадки / пд ред. проф. В. В. Нечаева. – СПб.: Изд-во СПбГМА им. И. И. Мечникова, 2010. – 65 с.
Нечаев В. В., Васильев В. В., Гаврилова Е. П. Инфекции, на которые распространяются международные медико-санитарные правила. Общие принципы санитарной охраны территорий. Эпидемиология и профилактика чумы, холеры, желтой лихорадки: уч. пос. для врачей / под ред. акад. РАМН, профессора Ю. В. Лобзина. Изд. СЗГМУ им. И. И. Мечникова. – 2012. – С. 35 – 42.
Чумаков М. П. Вирусные геморрагические лихорадки (научный обзор) ВНИИМИ. – М., 1979. – С. 10 – 33.
Bae H. G., Drosten C., Emmerich P. [et al.]. Analysis of two imported cases of yellow fever infection from Ivory Coast and the Gambia to Germany and Belgium // J. Clin. Virol. – 2005. – Vol. 33, № 4. – P. 274 – 280.
Вarnett E. D. Yellow fever: epidemiology and prevention // Clin. Infect. Dis. – 2007. – Vol. 44. – P. 850 – 856.
Bentlin M. R., de Barros Almeida R. A. M., Coelho K. I. R. [et al.]. Perinatal transmission of Yellow Fever. Brazil, 2009 // Emerg. Infect Dis. – 2011. – Vol. 17, № 9. – P. 1779 – 1780.
Cetron M. S., Marfin A. A., Julian K. G. [et al.]. CDC. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices // MMWR Recomm Rep. – 2002. – Vol. 51. – P. 1 – 11.
СDC. Fatal yellow fever in a traveler returning from Venezuela, 1999 // MMWR – 2000. – Vol. 49, № 14. – P. 303 – 305.
CDC. Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002 // MMWR. – 2002. – Vol. 51. – P. 324 – 325.
CDC. Outbreak Notice. Yellow Fever Alert in Brazil. – 2010. – 19 Nov.
СDC. Yellow fever Vaccine: Recommendation of the Advisory Committee on Immunization Practices (ACIP). Recommendation and Reports // MMWR. – 2010. – Vol. 59. – P. 1 – 27.
СDC. Vaccine Requirements and recommendations, by country. Yellow book. – [S. l.], 2010. – Ch. 2.
Gershman M., Schroeder B., Stahles J. E. Yellow fever. СDC. Travel-related Vaccine-Preventable Diseases. Yellow book. – [S. l.], 2012. – Ch. 2.
Gerasimon G., Lowry K. Rare case of fatal yellow fever vaccine-associated viscerotropic disease // South Med. J. – 2005. – Vol. 98, № 6. – P. 653 – 656.
Farnon E. C., Gould L. H., Griffith K. S. [et al.]. Househould-based sero-epidemiologic survey after a yellow fever epidemic, Sudan, 2005 // Am. J. Trop. Med. Hyg. – 2010. – Vol. 82, № 6. – P. 1146 – 1152.
Jentes E. S., Poumerol G., Gershman M. D. [et al.]. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever // Lancet Infect Dis. – 2011. – Vol. 11, № 8. – P. 622 – 628.
Khromava A. Y., Barwick R., Weld L. H. [et al.]. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events // Vaccine. – 2005. – Vol. 23, № 25. – P. 3256 – 3263.
Lawrence G. L. Burgess M. A., Kass R. B. Age-related risk of adverse events following yellow fever vaccination in Australia // Commun. Dis. Intell. – 2004. – Vol. 28, № 2. – P. 244 – 248.
McFarland J. M., Baadour L. M., Nelson J. E. [et al.]. Imported yellow fever in a United States citizen // Clin. Infect. Dis. – 1997. – Vol. 25, № 5. – P. 1143 – 1147.
Monath Th. P., Cetron M. S. Prevention of yellow fever in persons traveling to the tropics // Clin. Infect. Dis. – 2002. – Vol. 34, № 10. – P. 1369 – 1378.
Munoz J., Vilella A., Domingo C. [et al.]. Yellow fever-associated viscerotropic disease in Barcelona, Spain // J. Travel. Med. – 2008. – Vol. 15, № 3. – P. 202 – 205.
Mutebi J. P., Wang H., Li L. [et al.]. Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa // J. Virol. – 2001. – Vol. 75, № 15. – P. 6999 – 7008.
Mutebi J. P., Barrett A. D. The epidemiology of yellov fever in Africa // Microbes infect. – 2002. – Vol. 4, № 14. – P. 1459 – 1468.
Nolla-Salas J., Saballs-Radresa J., Bada J. L. Imported yellow fever in vaccinated tourist // Lancet. – 1989. – Vol. 2, № 8674. – P. 1275.
Norden J. D., Parker E. D., Vazquez-Benitez G. [et al.]. Safety of the Yellow Fever vaccine: A retrospective study // J. Travel Med. – 2013. – Vol. 20, № 6. – P. 368 – 373.
Pouliot S. H., Xiong X., Harville E. [et al.]. Maternal dengue and pregnancy outcomes: a systematic review // Obstet Gynecol Surv. – 2010. – Vol. 65, № 2. – P. 107 – 118.
Pugachev K. V., Ocran S. W., Guirakhoo F. [et al.]. Heterogenous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing // Vaccine. – 2002. – Vol. 20, № 7 – 8. – P. 996 – 999.
Reiter P. Yellow Fever and dengue: A threat to Europe? // Euro Surveillance. – 2010. – Vol. 15, № 10. – P. 19509.
Schwartz F., Drach F., Olsen J. [et al.]. Fatal Yellow Fever in a Traveler Returning from Venezuela, 1999 // MMWR. – 2000. – Vol. 49, № 14. – P. 303 – 305.
Seligman S. J. Yellow fever virus vaccine-associated deaths in young women // Emerg. Infect Dis. – 2011. – Vol. 17, № 10. – P. 1891 – 1893.
Staples J. E., Gershman M., Fischer M. Transmission of Yellow Fever vaccine virus through breast-feeding Brazil, 2009 // MMWR. – 2010. – Vol. 59, № 5. – P. 130 – 132.
Thomas P. M., Tsai T. P. Congenital arboviral infections: something new, something old // Pediatrics. – 2006. – Vol. 117, № 3. – P. 936 – 939.
Vainio